- A very good year end, driving an
excellent full-year performance for 2017 and demonstrating the
rationale of the Group’s strategy
- €8,326 million in sales,
up 10.5% on 2016, with 8.9% organic growth
- EBITDA up 17% to €1,391
million, led by strong growth for all three of the Group’s
divisions
- EBITDA margin at 16.7%
(15.8% in 2016)
- Adjusted net income up 42% to
€592 million, representing €7.82 per share (€5.56 per
share in 2016)
- Very strong cash generation, with
€565 million in free cash flow and a significant reduction
in net debt to €1,056 million (versus €1,482 million at 31
December 2016), i.e. 0.8 times 2017 EBITDA
- Proposed dividend increase from
€2.05 to €2.30 per share
Regulatory News:
The Board of Directors of Arkema (Paris:AKE) met on 21 February
2018 to approve the Group's consolidated financial statements for
2017 and the annual financial statements of the parent company. At
the close of the meeting, Chairman and CEO Thierry Le Hénaff
stated:
“Our very good performance in 2017 reflects the quality of our
underlying strategy and the strength of the growth projects for our
specialty businesses. We largely exceeded the medium-term financial
targets we set ourselves in 2014, with close to €1.4 billion in
EBITDA, excellent cash generation and a low level of debt.
The Group is reaping the benefits of its successful innovations
for advanced materials meeting our customers’ high demand for
lighter materials, new energies, 3D printing and consumer goods as
demonstrated by our ranking, for the seventh consecutive year, in
the Top 100 Global Innovators by Clarivate Analytics.
With Bostik, we have created a leading growth platform in
adhesives, which currently represents almost a quarter of our
overall sales. Bostik is proving all its potential, with its EBITDA
up by more than 50% since it joined Arkema three years ago.
Lastly, our intermediate chemical businesses achieved an
excellent performance supported by a very solid environment and the
development and productivity initiatives undertaken since several
years.
Arkema has demonstrated over the past three years and in
different types of operating contexts, the quality of its portfolio
of businesses with one of the best growth rates in its
industry.”
2017 KEY FIGURES
(In millions of euros)
2017
2016
Year-on-yearchange
Sales 8,326 7,535
+10.5% EBITDA
1,391 1,189 +17.0%
EBITDA margin 16.7 %
15.8 % Recurring depreciation and
amortization (449) (455)
-1.3%
Recurring operating income (REBIT)
942 734 +28.3%
REBIT margin 11.3% 9.7%
Depreciation and amortization related to purchase price
allocation* (45) (38) N/A
Other income and expenses* (52) 21
N/A
Operating income 845
717 +17.9% Adjusted
net income 592 418
+41.6% Net income – Group share
576 427 +34.9% Adjusted net income per
share (in €) 7.82 5.56
+40.6% Weighted average number of ordinary shares
75,682,844 75,201,739
* In the consolidated income statement, “Depreciation and
amortization related to the revaluation of tangible and intangible
assets as part of the purchase price allocation process” is now
recognized in “Operating expenses”. For 2016, other income and
expenses were restated to reflect this reclassification.
2017 BUSINESS PERFORMANCE
Sales totaled €8,326 million in 2017, up 10.5% on
2016. At constant exchange rates and business scope, the increase
was 8.9%. Volumes, which were 2.4% higher year on year,
significantly increased in High Performance Materials (+4.4%)
driven by Asia, the Group’s innovation drive and the startup of
new units. The price effect was positive for all three divisions
with a positive 6.5% price effect overall. This reflects the
actions taken by the Group to raise selling prices in specialty
businesses (which accounted for 71% of Group sales for the year)
and positive market conditions in intermediate chemical businesses
(which contributed 29% to the Group’s total sales figure1). The
scope effect added 3.3% to sales and included the contribution of
Den Braven as well as the impact of the divestment of the activated
carbon and filter aid business and the oxo alcohols business. The
currency effect was a negative 1.7%, primarily due to the
appreciation of the euro against the US dollar.
Broken down geographically, North America represented 32% of
Group sales, Europe 38% and Asia and the rest of the world 30%.
At €1,391 million, EBITDA reached an all-time
high, up 17% year on year and largely exceeding the €1.3 billion
target that the Group set itself in 2014 for 2017. All three
divisions reported EBITDA rises despite higher raw materials costs
than in 2016. This performance was led by Bostik’s growth, with in
particular the contribution of Den Braven, the benefits of
sustainability innovations and new manufacturing units for advanced
materials, excellent results from the Industrial Specialties
division, improvements in the acrylic cycle and operational
excellence initiatives.
EBITDA margin increased to16.7% from 15.8% in
2016, in line with the Group’s medium- and long-term targets.
Recurring operating income amounted to €942
million compared to €734 million in 2016, in line with EBITDA
increase. It includes €449 million in recurring depreciation and
amortization, which was overall stable compared to 2016
(€455 million). REBIT margin, which corresponds to
recurring operating income as a percentage of sales, rose to
11.3% from 9.7% in 2016.
At €845 million, operating income was up 18% year on
year. It included €52 million in net other expenses, roughly half
of which stemmed from the consequences of hurricane Harvey in the
United States and the remaining half from restructuring and
acquisition costs. It also included €45 million in depreciation and
amortization related to the revaluation of assets carried out as
part of the Bostik and Den Braven purchase price allocation
processes.
Financial result represented a net expense of €103
million, unchanged from 2016.
Income taxes represented a net expense of €162
million in 2017 versus a net €193 million expense in 2016.
Excluding exceptional items, the tax rate corresponded to 26% of
recurring operating income, down significantly on the 29% rate for
2016 due to the more balanced geographic split of the Group’s
results in 2017. The income tax expense figure comprises various
exceptional items, including a one-time €36 million gain with no
cash impact arising from the adjustment of deferred taxes following
the decrease in corporate tax rate announced in the United States.
In view of the Group’s strong position that it has built up in the
United States and based on its 2017 results, Arkema will benefit
with the US tax reform from an estimated tax saving representing
around 6% of its adjusted net income, which will reduce its tax
rate to around 23% of recurring operating income. This tax saving
comes at a time when the Group is substantially increasing its
capital expenditure in the United States.
Net income – Group share rose sharply to €576
million from €427 million in 2016. Excluding the post-tax
impact of non-recurring items, adjusted net income came to
€592 million, representing €7.82 per share (up 41% on
2016).
In line with the Group’s dividend policy, the Board of Directors
has decided that at the Annual General Meeting of 18 May 2018 it
will recommend increasing the dividend to be paid entirely in cash
from €2.05 per share to €2.30, representing a payout rate of
almost 30% of the Group’s adjusted net income. Shares will be
traded ex-dividend on 25 May 2018 and the dividend will be paid as
from 29 May 2018.
2017 PERFORMANCE BY DIVISION
HIGH PERFORMANCE MATERIALS (46% OF TOTAL GROUP SALES)
(In millions of euros)
2017
2016
Year-on-yearchange
Sales 3,830 3,422
+11.9% EBITDA 632
570 +10.9% EBITDA
margin 16.5% 16.7%
Recurring operating income (REBIT)
474 416
+13.9% REBIT margin 12.4% 12.2%
Sales generated by the High Performance Materials
division totaled €3,830 million, up 11.9% on 2016. The scope
effect was a positive 8.0%, reflecting the integration of Den
Braven and the CMP business within Bostik as well as the divestment
of the activated carbon and filter aid business. At constant
exchange rates and business scope, year-on-year sales growth was
5.9%, led by a 4.4% increase in volumes. Volumes rose for all the
division’s businesses, driven in particular by very high demand in
Asia for lighter materials, new energies (batteries and
photovoltaics) and consumer goods (sports and consumer electronics)
as well as by the contribution of the new specialty molecular
sieves unit in Honfleur (France). The price effect was a positive
1.5%, reflecting the actions undertaken by the Group to raise its
selling prices. The currency effect was a negative 2.1%.
At €632 million, EBITDA increased 10.9% year on
year, supported by strong volume momentum for advanced materials
(Technical Polymers and Performance Additives), as well as by
Bostik’s growth fueled by the integration of Den Braven and the
benefits of first synergies. This strong rise was achieved despite
the significant impact of higher costs for certain raw materials
and the stronger euro versus the US dollar.
At 16.5%, EBITDA margin held firm compared with the 16.7%
margin for 2016.
INDUSTRIAL SPECIALTIES (31% OF TOTAL GROUP SALES)
(In millions of euros)
2017
2016
Year-on-yearchange
Sales 2,545 2,316
+9.9% EBITDA 585
473 +23.7% EBITDA
margin 23.0% 20.4%
Recurring operating income (REBIT)
411 300
+37.0% REBIT margin 16.1% 13.0%
Industrial Specialties sales were up 9.9% year on year to
€2,545 million. At constant exchange rates and business
scope, sales growth was 11.3%, driven by a 9.6% positive price
effect reflecting higher prices for certain fluorogases
particularly in Europe and Asia, and positive market conditions in
the MMA/PMMA chain. Volumes were 1.7% higher than in 2016, driven
mainly by good demand in Thiochemicals. The currency effect was a
negative 1.4%.
At €585 million, EBITDA increased 23.7% year on
year and EBITDA margin reached 23% in a market
boosted by robust global growth and a more intense environmental
policy in China. Against this backdrop, the division’s results
reflect the return of Fluorogases to a very good level of results,
a tight supply/demand situation in the MMA/PMMA business, and a
solid performance by Thiochemicals and Hydrogen Peroxide.
COATING SOLUTIONS (23% OF TOTAL GROUP SALES)
(In millions of euros)
2017
2016
Year-on-yearchange
Sales 1,924 1,771
+8.6% EBITDA 244
208 +17.3% EBITDA
margin 12.7% 11.7%
Recurring operating income (REBIT)
135 83
+62.7% REBIT margin 7.0% 4.7%
At €1,924 million, sales for the Coating Solutions
division rose 8.6% on 2016, led by a 12.1% positive price effect
thanks to a better acrylic cycle as well as measures taken to raise
selling prices across the entire chain. Volumes were generally
stable year on year (edging down just 0.4%), as higher volumes in
the division’s downstream businesses offset the impact in the
Acrylics business of maintenance turnarounds. The divestment of the
oxo-alcohol business resulted in a 1.5% negative scope effect and
the currency effect was a negative 1.5%.
The division’s EBITDA amounted to €244 million, up
17.3% year on year, and EBITDA margin rose to 12.7%
from 11.7% in 2016. As the Group expected, unit margins for acrylic
monomers gradually improved from the low points seen in 2016, and
were positioned in 2017 between the low and mid point of the cycle.
This more than offset the impact of higher input costs on
downstream businesses.
CASH FLOW AND NET DEBT AT 31 DECEMBER 2017
In 2017, Arkema generated a high level of free cash flow
(which corresponds to net cash flow excluding the impact of
portfolio management), with a year-on-year increase of €139 million
to €565 million (€426 million in 2016). This increase
reflects the significant rise in EBITDA and tight control of
working capital despite a context of rising raw materials costs. At
31 December 2017, the ratio of working capital to annual sales
reached a record low at 13.1% compared with 14.5% at 31 December
2016 (excluding Den Braven which was acquired in late 2016). This
ratio, which was positively impacted by the appreciation of the
euro, mainly reflects the continuing implementation of a strict
operational discipline and the optimization drive conducted in
several businesses.
The free cash flow also includes €431 million in recurring
capital expenditure 2 (representing 5.2% of Group sales) as
well as €10 million in exceptional investments for the initial work
undertaken as part of the project to double thiochemical production
capacity in Malaysia.
In 2018 Arkema expects capital expenditure to amount to around
€550 million, corresponding to recurring capital expenditure
representing around 5.5% of sales and to exceptional investments
for the specialty polyamides project in Asia and the thiochemicals
project in Malaysia presented at Arkema’s Capital Markets Day in
July 2017.
Finally, free cash flow also included €54 million in
non-recurring expenses, primarily relating to the consequences of
hurricane Harvey in the United States and restructuring costs.
Free cash flow excluding exceptional investments represented 41%
of EBITDA for 2017, thus exceeding the Group’s target of a 35%
EBITDA conversion rate into cash. This performance is in the top
range for the industry as a whole.
Portfolio management operations represented a net cash outflow
of just €5 million in 2017, with the impact of the purchase of the
assets of CMP Specialty Products in the adhesives business almost
entirely offsetting the effect of the divestment of the oxo
alcohols business.
Cash flow from financing activities totaled €192
million in 2017 and included a bond issue for a total net
amount of €891 million, the repayment of a bond that had reached
maturity for a net amount of €494 million, the payment of a €2.05
per-share dividend totalling €155 million and a €33 million
coupon paid on a hybrid bond.
At 31 December 2017 net debt stood at €1,056
million, down significantly on the €1,482 million net debt
figure at 31 December 2016. The Group’s gearing decreased to
24% from 35% at end-December 2016 and net debt represented 0.8
times EBITDA for the year. In accordance with IFRS standards, these
figures exclude the hybrid bond.
KEY FIGURES FOR FOURTH-QUARTER 2017
(In millions of euros)
Q4 2017
Q4 2016
Year-on-yearchange
Sales 1,957 1,852
+5.7% EBITDA 283
243 +16.5% High
Performance Materials 131 116 +12.9% Industrial Specialties 120 87
+37.9% Coating Solutions 44 41
+7.3%
EBITDA margin 14.5% 13.1%
High Performance Materials
14.4%
13.8%
Industrial Specialties
19.8%
15.3%
Coating Solutions
10.1%
9.3%
Depreciation, amortization and impairment
(118) (119) -0.8%
Recurring operating income (REBIT) 165
124 +33.1% REBIT margin
8.4% 6.7%
Adjusted net income 115
68 +69.1% Net income – Group share
137 86 +59.3% Adjusted
net income per share (in €) 1.52 0.90
+68.9%
In the fourth quarter of 2017, sales rose 6.7% year on
year to €1,957 million at constant exchange rates and
business scope. The price effect was positive for all three
divisions with a positive 6.7% price effect overall. This reflects
the actions taken by the Group to raise its selling prices for
specialty businesses as well as continuously positive market
conditions for intermediate chemical businesses. Despite a 4%
increase in volumes for advanced materials, volumes for the Group
as a whole remained overall stable against the high basis of
comparison of the fourth quarter of 2016, particularly in the
Coating Solutions division. The scope effect was a positive 3.7%
and included the contribution of Den Braven as well as the impact
of the divestment of the oxo alcohols business. The currency effect
was a negative 4.7%, primarily attributable to the stronger euro
versus the US dollar.
Against this backdrop EBITDA was up 16.5% to
€283 million and EBITDA margin reached 14.5%
compared to 13.1% in fourth-quarter 2016, despite much higher raw
materials costs in fourth-quarter 2017 and the stronger euro versus
the US dollar. This performance was led by higher volumes for
advanced materials, the benefits from Den Braven’s integration and
first synergies, as well as a very good performance from the
Industrial Specialties division.
The High Performance Materials division delivered a good
performance in spite of higher raw materials costs and the stronger
euro. At €909 million, the division’s sales rose 8.3% on
fourth-quarter 2016, led by a 9.3% positive scope effect, mainly
related to the integration of Den Braven and CMP. At constant
exchange rates and business scope, year-on-year sales growth came
to 3.5%, driven by a 4% increase in volumes for advanced materials
driven by Asia and innovation. EBITDA came to €131 million, up
12.9% on fourth-quarter 2016, reflecting the strong sales rise.
The Industrial Specialties division achieved another very
good quarter, with sales up 6.7% year on year to €606 million.
At constant exchange rates and business scope, the increase was
11.7% led by a 13.3% positive price effect, with a positive price
effect for all of the division’s businesses. At €120 million, the
division’s EBITDA surged 37.9%, supported by increases across all
of the division’s businesses and reflecting the continuing tight
market conditions for the MAM/PMMA chain as well as good results
from the Fluorogases business despite the usual year-end
seasonality.
The Coating Solutions division reported a slight increase
against a high basis of comparison in the fourth quarter of 2016,
especially for Asia. At €437 million, Coating Solutions sales were
generally stable versus fourth-quarter 2016, edging down just 0.7%,
with a 2.1% negative scope effect following the divestment of the
oxo alcohols business. At constant exchange rates and business
scope, sales rose 6.3% on the fourth quarter of 2016, thanks to a
9.0% positive price effect. EBITDA increased by 7.3% to €44
million, with better margins for acrylic monomers in Europe and the
United States more than offsetting the impact in downstream
businesses of higher input costs.
POST BALANCE SHEET EVENTS
In line with its strategy of continuing to expand in adhesives,
on 2 January 2018 Bostik acquired the assets of XL Brands, a
leader in floor covering adhesives in the United States. This
transaction, based on a US$205 million enterprise value, will
enable Bostik to offer a full range of solutions for this growing
high added-value market. The Group aims to reduce the EV/EBITDA
multiple paid from 11 times to 7 times within four to five years
and after implementing synergies.
In February 2018, Arkema announced a 25% increase of its global
polyamide 12 production capacities. This new capacity will be added
at Arkema’s Changshu platform in China and is expected to come on
stream by mid-2020. This investment of a few tens of millions of
euros will support the strong demand in growing applications such
as cable protection, lighter materials in automobiles, high
performance sports shoes and consumer electronics.
OUTLOOK FOR 2018
In 2018, demand in the three main geographic regions should
remain well oriented and the environment characterized by a marked
strengthening of the euro versus the US dollar 3 and higher
and volatile raw materials costs.
Against this backdrop, the Group will benefit from its strong
innovation drive in advanced materials, from Bostik’s growth
with the integration of XL Brands and from a market environment
expected to remain globally robust for its intermediate chemical
businesses. It will continue to implement its major manufacturing
projects, as presented during its Capital Markets Day, for
thiochemicals, specialty polyamides, fluoropolymers and
Sartomer.
Lastly, the Group will continue its actions to pass on in its
selling prices the continuous rises in raw materials costs as well
as the rollout of its operational excellence initiatives to partly
offset inflation on its fixed costs.
Supported by a good start of the year and this strong internal
momentum and despite the euro’s current strength, Arkema is
confident in its ability to increase its EBITDA in 2018 compared to
the excellent performance achieved in 2017.
Further details on the 2017 results and outlook are provided in
the "Full year 2017 results" presentation available on Arkema’s
website at www.finance.arkema.com
The consolidated financial statements at 31 December 2017 have
been audited, and an unqualified certification report has been
issued by the Company's statutory auditors. These accounts and the
statutory auditors’ report will be available at end-March in the
Company’s reference document which will be posted online on
Arkema’s website at www.finance.arkema.com
FINANCIAL CALENDAR
3 May 2018
Publication of 1st quarter 2018
results
18 May 2018 Annual General Meeting 1 August 2018
Publication of 1st half 2018 results
6 November 2018
Publication of 3rd quarter 2018
results
A designer of materials and innovative solutions, Arkema
shapes materials and creates new uses that accelerate customer
performance. Our balanced business portfolio spans High Performance
Materials, Industrial Specialties and Coating Solutions. Our
globally recognized brands are ranked among the leaders in the
markets we serve. Reporting annual sales of €8.3 billion in 2017,
we employ around 20,000 people worldwide and operate in some 50
countries. We are committed to active engagement with all our
stakeholders. Our research centers in North America, France and
Asia concentrate on advances in bio-based products, new energies,
water management, electronic solutions, lightweight materials and
design, home efficiency and insulation. www.arkema.com
DISCLAIMER
The information disclosed in this press release may contain
forward-looking statements with respect to the financial position,
results of operations, business and strategy of Arkema. Such
statements are based on management's current views and assumptions
that could ultimately prove inaccurate and are subject to risk
factors such as (but not limited to) changes in raw materials
prices, currency fluctuations, the pace at which cost-reduction
projects are implemented and changes in general economic and
financial conditions. Arkema does not assume any liability to
update such forward-looking statements whether as a result of any
new information or any unexpected event or otherwise. Further
information on factors which could affect Arkema's financial
results is provided in the documents filed with the French Autorité
des marchés financiers.
Balance sheet, income statement and cash flow statement data as
well as data relating to the statement of changes in shareholders'
equity and information by business division included in this press
release are extracted from the consolidated financial statements at
31 December 2017 as reviewed by Arkema’s Board of Directors on 21
February 2018. Quarterly financial information is not audited.
Information by business division is presented in accordance with
Arkema's internal reporting system used by management.
Details of the main alternative performance indicators used by
the Group are provided in the tables appended to this press
release.
For the purpose of analyzing its results and defining its
targets, the Group also uses the following indicators:
• REBIT margin: recurring operating income (REBIT)
as a percentage of sales.
• free cash flow: net cash flow from operating and
investing activities excluding the impact of portfolio
management.
For the purpose of tracking changes in its results, and
particularly its sales figures, the Group analyzes the following
effects (unaudited analyses):
• business scope effect: the impact of changes in
the Group’s scope of consolidation, which arise from acquisitions
and divestments of entire businesses or as a result of the
first-time consolidation or deconsolidation of entities. Increases
or reductions in capacity are not included in the scope effect.
• currency effect: the mechanical impact of
consolidating accounts denominated in currencies other than the
euro at different exchange rates from one period to another. The
currency effect is calculated by applying the foreign exchange
rates of the prior period to the figures for the period under
review.
• price effect: the impact of changes in average
selling prices is estimated by comparing the weighted average net
unit selling price of a range of related products in the period
under review with their weighted average net unit selling price in
the prior period, multiplied, in both cases, by the volumes sold in
the period under review.
• volume effect: the impact of changes in volumes
is estimated by comparing the quantities delivered in the period
under review with the quantities delivered in the prior period,
multiplied, in both cases, by the weighted average net unit selling
price in the prior period.
1 Acrylics, Fluorogases and PMMA.2 Excluding exceptional capex
and capex relating to portfolio management.3 10% increase in euro /
US dollar exchange rate has a €(50) m EBITDA impact
(translation).
ARKEMA Financial Statements
Consolidated financial statements - At the
end of December 2017
CONSOLIDATED INCOME STATEMENT
4th quarter
2017
End of December
2017
3rd
quarter 2016
End of December
2016
(In millions of euros) (non audited)
(audited) (non audited) (audited)
Sales
1,957
8,326
1,852
7,535
Operating expenses*
(1,559)
(6,467)
(1,504)
(5,926)
Research and development expenses (59) (235) (57) (222) Selling and
administrative expenses (185) (727) (177) (691) Other income and
expenses* (32) (52) 13
21
Operating income 122
845 127
717 Equity in income of affiliates 1 1 1 8 Financial result
(25) (103) (28) (103) Income taxes 40
(162) (16) (193)
Net income
138 581
84 429 Of which non-controlling
interests 1 5 (2)
2
Net income - Group share 137
576 86
427 Earnings per share (amount in euros)** 1.37 7.17 0.7
5.24 Diluted earnings per share (amount in euros)**
1.36 7.15 0.69 5.22
* Depreciation and amortization associated with revaluation of
tangible and intangible assets for allocation of the purchase price
of businesses previously included in “Other income and expenses”
(see note C4 “Other income and expenses”) have been reclassified as
“Operating expenses”.** From 2017, in accordance with
IAS 33, the earnings per share and diluted earnings per share
are calculated based on net income (Group share) less the
net-of-tax interest paid to bearers of subordinated perpetual notes
(hybrid bonds). The 2016 figures have been restated
accordingly.
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
4th quarter
2017
End of December
2017
3rd
quarter 2016
End of December
2016
(In millions of euros) (non audited)
(audited) (non audited) (audited)
Net income 138 581
84 429 Hedging
adjustments (5) 20 (20) (6) Other items (4) (4) 1 (6) Deferred
taxes on hedging adjustments and other items - - (1) (2) Change in
translation adjustments (17) (200)
68 7
Other recyclable comprehensive
income (26) (184)
48 (7) Actuarial gains
and losses 16 32 16 13 Deferred taxes on actuarial gains and losses
(6) (11) (10)
(12)
Other non-recyclable comprehensive income
10 21 6
1 Total income and expenses recognized
directly in equity (16)
(163) 54 (6)
Comprehensive income 122
418 138 423 Of
which: non-controlling interest 4 5
(1) -
Comprehensive income - Group
share 118 413
139 423 INFORMATION BY
BUSINESS SEGMENT
4th quarter 2017
(In millions of euros)
HighPerformanceMaterials
IndustrialSpecialties
CoatingSolutions
Corporate Total Non-Group sales 909 606 437 5
1,957
Inter segment sales 2 34 17 -
Total sales
911 640 454
5 EBITDA
131 120 44
(12) 283 Recurring depreciation
and amortization (42) (42)
(28) (6) (118)
Recurring
operating income (REBIT) 89
78 16 (18)
165 Depreciation and amortization associated with
revaluation of tangible and intangible assets for allocation of the
purchase price of businesses
(11) - - -
(11) Other income and expenses (5) (7) (7) (13) (32)
Operating income 73
71 9 (31)
122 Equity in income of affiliates 0 1 - - 1
Intangible assets and property, plant and equipment
additions 74 79 43 11 207 Of
which Recurring capital expenditure 74 73 43 11 201
4th quarter 2016 (In millions of euros)
HighPerformanceMaterials
IndustrialSpecialties
CoatingSolutions
Corporate Total Non-Group sales 839 568 440 5
1,852
Inter segment sales 2 25 14 -
Total sales
841 593 454
5 EBITDA
116 87 41
(1) 243 Recurring depreciation
and amortization (39) (44)
(35) (1) (119)
Recurring
operating income 77
43 6 (2)
124 Depreciation and amortization associated with
revaluation of tangible and intangible assets for allocation of the
purchase price of businesses (10) - - - (10) Other income and
expenses 65 (48) - (4) 13
Operating income
132 (5) 6
(6) 127 Equity in income of
affiliates - 1 - - 1
Intangible assets and property,
plant and equipment additions 75 64 38
5 182 Of which Recurring capital expenditure 73 65 38
5 181
INFORMATION BY BUSINESS SEGMENT (audited)
End of December 2017 (In millions of euros)
HighPerformanceMaterials
IndustrialSpecialties
CoatingSolutions
Corporate Total Non-Group sales
3,830
2,545
1,924
27
8,326
Inter segment sales 7 141 72 -
Total sales
3,837
2,686
1,996
27 EBITDA
632 585 244
(70)
1,391
Recurring depreciation and amortization (158)
(174) (109) (8)
(449)
Recurring operating income (REBIT)
474 411 135
(78) 942 Depreciation and
amortization associated with revaluation of tangible and intangible
assets for allocation of the purchase price of businesses
(45) - - - (45) Other income and
expenses (19) (9) (8) (16) (52)
Operating income
410 402 127
(94) 845 Equity in income
of affiliates 1 0 - - 1
Intangible assets and property,
plant and equipment additions 186 165 88
20 459 Of which Recurring capital expenditure 168 155
88 20 431
End of December 2016 (In millions of
euros)
HighPerformanceMaterials
IndustrialSpecialties
CoatingSolutions
Corporate Total Non-Group sales
3,422
2,316
1,771
26
7,535
Inter segment sales 14 109 56 -
Total sales
3,436
2,425
1,827
26 EBITDA
570 473 208
(62)
1,189
Recurring depreciation and amortization (154)
(173) (125) (3)
(455)
Recurring operating income 416
300 83
(65) 734 Depreciation and amortization
associated with revaluation of tangible and intangible assets for
allocation of the purchase price of businesses
(38) -
- - (38) Other income and expenses 60 (61) 2
20 21
Operating income 438
239 85 (45)
717 Equity in income of affiliates 1 7 - - 8
Intangible assets and property, plant and equipment
additions 175 175 82 13 445
Of which Recurring capital expenditure 173 155 82 13 423
CONSOLIDATED BALANCE SHEET
End of December
2017
End of December
2016
(In millions of euros) (audited) (audited)
ASSETS Intangible assets, net 2,706 2,777 Property,
plant and equipment, net 2,464 2,652 Equity affiliates :
investments and loans 30 35 Other investments 30 33 Deferred tax
assets 150 171 Other non-current assets 230 227
TOTAL
NON-CURRENT ASSETS 5,610
5,895 Inventories 1,145 1,111 Accounts receivable
1,115 1,150 Other receivables and prepaid expenses 181 197 Income
taxes recoverable 70 64 Other current financial assets 17 10 Cash
and cash equivalents 1,438 623
TOTAL CURRENT ASSETS
3,966 3,155 TOTAL ASSETS
9,576 9,050 LIABILITIES AND
SHAREHOLDERS' EQUITY Share capital 759 757 Paid-in
surplus and retained earnings 3,575 3,150 Treasury shares (2) (4)
Translation adjustments 101 301
SHAREHOLDERS' EQUITY - GROUP
SHARE 4,433 4,204
Non-controlling interests 41 45
TOTAL SHAREHOLDERS' EQUITY 4,474
4,249 Deferred tax liabilities 271 285
Provisions for pensions and other employee benefits 460 520 Other
provisions and non-current liabilities 443 464 Non-current debt
2,250 1,377
TOTAL NON-CURRENT LIABILITIES
3,424 2,646 Accounts payable 965
932 Other creditors and accrued liabilities 377 402 Income taxes
payable 82 62 Other current financial liabilities 10 31 Current
debt 244 728
TOTAL CURRENT LIABILITIES
1,678 2,155 TOTAL LIABILITIES AND
SHAREHOLDERS' EQUITY 9,576 9,050
CONSOLIDATED CASH FLOW STATEMENT
End of December
2017
End of December
2016
(In millions of euros) (audited) (audited)
Cash flow - operating activities Net income 581 429
Depreciation, amortization and impairment of assets 501 530
Provisions, valuation allowances and deferred taxes (41) (56)
(Gains)/losses on sales of assets (2) (106) Undistributed affiliate
equity earnings 2 (5) Change in working capital (41) 11 Other
changes 8 18
Cash flow from operating activities
1,008 821 Cash flow -
investing activities Intangible assets and property,
plant, and equipment additions (459) (445) Change in fixed asset
payables 6 (37) Acquisitions of operations, net of cash acquired
(1) (338) Increase in long-term loans (60) (62)
Total
expenditures (514) (882) Proceeds from
sale of intangible assets and property, plant and equipment 10 118
Change in fixed asset receivables 0 0 Proceeds from sale of
operations, net of cash sold 11 43 Proceeds from sale of
unconsolidated investments 0 19 Repayment of long-term loans 45 38
Total divestitures 66 218
Cash flow from investing
activities (448)
(664) Cash flow - financing activities
Issuance (repayment) of shares and other equity 3 51 Purchase of
treasury shares (17) (6) Dividends paid to parent company
shareholders (188) (176) Dividends paid to non-controlling
interests (4) (4) Increase/ decrease in long-term debt 870 (38)
Increase/ decrease in short-term borrowings and bank overdrafts
(472) (83)
Cash flow from financing
activities 192 (256)
Net increase/(decrease) in cash and cash equivalents 752
(99) Effect of exchange rates and changes in scope 63 11
Cash and cash equivalents at beginning of period 623
711
Cash and cash equivalents at end of period
1,438 623
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY
(audited)
Shares
issued Treasury
shares
Shareholders'equity -
Groupshare
Non-controllinginterests
Shareholders'equity
(In millions of euros)
Number Amount
Paid-insurplus
Hybridbonds
Retainedearnings
Translationadjustments
Number Amount
At January 1, 2017 75,717,947
757 1,211 689
1,250 301 (65,823)
(4) 4,204 45 4,249
Cash dividend - - - - (188) - - - (188) (4) (192)
Issuance of share capital 152,559 2 5 - - - - - 7 - 7 Purchase of
treasury shares - - - - - - (180,000) (17) (17) - (17) Grants of
treasury shares to employees - - - - (19) - 212,598 19 - - -
Share-based payments - - - - 13 - - - 13 - 13 Other -
- - - 1 - - - 1
(5) (4)
Transactions with shareholders
152,559 2 5 -
(193) - 32,598
2 (184) (9) (193)
Net income - - - - 576 - - - 576 5 581 Total income and expense
recognized directly through equity - - -
- 37 (200) - - (163)
- (163)
Comprehensive income -
- - - 613
(200) - -
413 5 418 At December 31,
2017 75,870,506 759
1,216 689 1,670
101 (33,225) (2)
4,433 41 4,474
ALTERNATIVE PERFORMANCE INDICATORS
To monitor and analyse the financial performance of the Group
and its activities, the Group management uses alternative
performance indicators. These are financial indicators that are not
defined by the IFRS. A reconciliation of these indicators and the
aggregates from the consolidated financial statements under IFRS is
presented below.
RECURRING OPERATING INCOME (REBIT) AND EBITDA
(In millions of
euros)
End of December
2017
End of December
2016
4th quarter
2017
4th quarter
2016
OPERATING INCOME 845 717 122 127
- Depreciation and amortization associated with revaluation of
tangible and intangible assets for allocation of the purchase price
of businesses (45) (38) (11) (10) - Other income and expenses (52)
21 (32) 13
RECURRING OPERATING INCOME (REBIT)
942 734 165 124 -
Recurring depreciation and amortization (449) (455) (118) (119)
EBITDA 1,391 1,189
283 243
Details of
depreciation and amortizations:
(In
millions of euros)
End of December
2017
End of December
2016
4th quarter
2017
4th quarter
2016
Depreciation and amortization (501)
(530) (136) (162) Of which:
Impairment included in other income and expenses (449) (455) (118)
(119) Of which: Recurring depreciation and amortization (45) (38)
(11) (10) Of which: Depreciation and amortization associated with
revaluation of assets for allocation of the purchase price of
businesses (7) (37) (7) (33)
ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE
(In
millions of euros)
End of December
2017
End of December
2016
4th quarter
2017
4th quarter
2016
NET INCOME - GROUP SHARE 576 427 137
86 - Depreciation and amortization associated with
revaluation of assets for allocation of the purchase price of
businesses (45) (38) (11) (10) - Other income and expenses (52) 21
(32) 13 - Other income and expenses - Non-controlling interests - 3
- 3 - Taxes on depreciation and amortization associated with
revaluation of assets for allocation of the purchase price of
businesses 12 10 2 1 - Taxes on other income and expenses 14 4 8 2
- One-time tax-effects 55 9 55 9
ADJUSTED NET INCOME
592 418 115 68 -
Weighted average number of ordinary shares 75,682,844 75,201,739 -
Weighted average number of potential ordinary shares 75,895,729
75,429,599
ADJUSTED EARNINGS PER SHARE (€)
7,82 5,56 1,52
0,90 DILUTED ADJUSTED EARNINGS PER SHARE (€)
7,80 5,54 1,52
0,89 FREE CASH FLOW
(In millions of
euros)
End of December
2017
End of December
2016
4th quarter
2017
4th quarter
2016
Cash
flow from operating activities 1,008 821 350 246 + Cash flow from
investing activities (448) (664) (174)
(327)
NET CASH FLOW 560 157
176 (81) - Net cash flow from portfolio
management operations (5) (269) (1)
(220)
FREE CASH FLOW 565 426
177 139 RECURRING
INVESTMENTS
(In millions of euros)
End of December
2017
End of December
2016
4th quarter
2017
4th quarter
2016
INTANGIBLE ASSETS AND PROPERTY, PLANT, AND EQUIPMENT
ADDITIONS 459 445* 207 182 -
Exceptional investments 10 - 6 - - Investments relating to
portfolio management operations 18 - - - - Investments with no
impact on net debt - 22 - 1
RECURRING INVESTMENTS
431 423 201 181
* The 2016 figures have been corrected by €2 million,
in coherence with the cash flow statement.
NET DEBT (In millions of
euros)
End of December
2017
End of December
2016
Non-current debt 2,250 1,377 Current debt 244 728 Cash and
cash equivalents 1,438 623
NET DEBT 1,056
1,482 WORKING CAPITAL
(In millions of euros)
End of December
2017
End of December
2016
Inventories 1,145 1,111 Accounts receivable 1,115 1,150
Other receivables including income taxes 251 261 Accounts payable
(965) (932) Other liabilities including income taxes (459) (464)
Derivatives 7 (21)
WORKING CAPITAL 1,094
1,105 CAPITAL EMPLOYED
(In millions of euros)
End of December
2017
End of December
2016
Goodwill, net 1,525 1,703
Intangible assets other than goodwill, and property, plant and
equipment, net 3,645 3,726 Investments in equity affiliates 30 35
Other investments and other non-current assets 260 260 Working
capital 1,094 1,105
CAPITAL EMPLOYED
6,554 6,829
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180221006329/en/
INVESTOR RELATIONS CONTACTSSophie Fouillat+33 1 49 00 86
37sophie.fouillat@arkema.comFrançois Ruas+33 1 49 00 72
07francois.ruas@arkema.comorMEDIA CONTACTGilles Galinier+33
1 49 00 70 07gilles.galinier@arkema.com
Arkema (EU:AKE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arkema (EU:AKE)
Historical Stock Chart
From Apr 2023 to Apr 2024